Vanguard Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.46M | Buy |
|
|||||
|
2025
Q1 | $7.6M | Buy |
|
|||||
|
2024
Q4 | $10.7M | Sell |
|
|||||
|
2024
Q3 | $5.39M | Sell |
|
|||||
|
2024
Q2 | $5.16M | Sell |
|
|||||
|
2024
Q1 | $6.11M | Buy |
|
|||||
|
2023
Q4 | $4.96M | Buy |
|
|||||
|
2023
Q3 | $23M | Buy |
|
|||||
|
2023
Q2 | $34.5M | Buy |
|
|||||
|
2023
Q1 | $25.8M | Buy |
|
|||||
|
2022
Q4 | $49.2M | Buy |
|
|||||
|
2022
Q3 | $46.1M | Buy |
|
|||||
|
2022
Q2 | $39.3M | Buy |
|
|||||
|
2022
Q1 | $47M | Buy |
|
|||||
|
2021
Q4 | $39.5M | Buy |
|
|||||
|
2021
Q3 | $48.2M | Buy |
|
|||||
|
2021
Q2 | $45.1M | Buy |
|
|||||
|
2021
Q1 | $53.4M | Buy |
|
|||||
|
2020
Q4 | $9.62M | Buy |
|
|||||
|
2020
Q3 | $3.34M | Hold |
|
|||||
|
2020
Q2 | $2.11M | Sell |
|
|||||
|
2020
Q1 | $1.46M | Sell |
|
|||||
|
2019
Q4 | $2.67M | Buy |
|
|||||
|
2019
Q3 | $1.49M | Sell |
|
|||||
|
2019
Q2 | $4.09M | Buy |
|
|||||
|
2019
Q1 | $11M | Buy |
|
|||||
|
2018
Q4 | $5.33M | Sell |
|
|||||
|
2018
Q3 | $17.3M | Sell |
|
|||||
|
2018
Q2 | $23.9M | Buy |
|
|||||
|
2018
Q1 | $20.5M | Buy |
|
|||||
|
2017
Q4 | $27.8M | Sell |
|
|||||
|
2017
Q3 | $30.6M | Buy |
|
|||||
|
2017
Q2 | $22M | Buy |
|
|||||
|
2017
Q1 | $21.2M | Buy |
|
|||||
|
2016
Q4 | $16.4M | Buy |
|
|||||
|
2016
Q3 | $10.9M | Buy |
|
|||||
|
2016
Q2 | $7.74M | Buy |
|
|||||
|
2016
Q1 | $3.21M | Buy |
|
|||||
|
2015
Q4 | $4.04M | Buy |
|